PF-Atlas › Клинические испытания › NCT05290441
Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 Pneumonia
None involvement · Не указано
ID реестра
NCT05290441
Фаза
Не указано
Статус
Завершено
Препарат / вмешательство
None involvement
Спонсор
Bursa Yuksek Ihtisas Training and Research Hospital
Начало
2021-08-15
Набор участников
65
Центры
2
Об исследовании
The aim of this study is to examine the relationship between the severity of fibrosis in the lung tissue and EGFR positivity in patients who died due to covid-19 pneumonia, with the demographic characteristics, comorbidities, biochemistry values, treatments they received, and radiological appearances. Transthoracic tru-cut biopsy will be performed on patients who have died in the intensive care unit with the diagnosis of Covid 19 pneumonia. EGFR positivity will be evaluated in the material taken. The relationship between the severity of fibrosis and the demographic data of the patients, the drugs used and their radiological appearances will be analyzed statistically.
Связанные материалы
Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT05290441 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.